Stock Analysis on Net
AI Tokens
Stock Analysis on Net

Abiomed Inc. (NASDAQ:ABMD)

This company has been moved to the archive! The financial data has not been updated since November 3, 2022.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

Abiomed Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016
Accounts payable 2.07 2.04 2.11 2.01 1.81 2.04 2.33 1.65 1.64 2.22 2.69 2.64 2.82 2.64 3.05 2.74 2.47 3.16 3.00 3.06 2.40 1.96 3.75 2.91 2.96 1.95
Accrued expenses 4.09 4.64 4.34 4.19 3.71 3.87 4.42 5.02 4.31 4.68 6.17 6.01 5.15 4.62 5.45 5.40 5.20 4.79 5.87 5.78 5.08 5.47 6.85 6.89 5.90 6.12
Deferred revenue 1.53 1.39 1.58 1.56 1.57 1.65 1.63 1.49 1.61 1.59 1.57 1.60 1.72 1.44 1.55 1.58 1.58 1.49 1.90 1.64 1.52 1.49 1.91 1.80 1.92 2.00
Other current liabilities 0.21 0.20 0.25 0.20 0.36 0.19 0.25 0.27 0.37 0.34 0.40 0.31 0.29 0.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current portion of capital lease obligation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.13 0.15 0.15 0.16 0.00
Current liabilities 7.90% 8.26% 8.27% 7.96% 7.45% 7.76% 8.63% 8.43% 7.92% 8.83% 10.84% 10.55% 9.98% 8.91% 10.05% 9.71% 9.24% 9.44% 10.77% 10.47% 9.12% 9.05% 12.65% 11.75% 10.93% 10.07%
Other long-term liabilities 0.41 0.46 0.56 0.68 0.54 0.78 0.68 1.19 0.88 0.75 0.76 1.02 0.86 1.02 0.10 0.12 0.10 0.10 0.10 0.06 0.09 0.09 0.59 0.00 0.00 0.05
Contingent consideration 0.88 1.07 1.29 1.35 1.46 1.75 1.65 1.77 1.84 1.90 0.74 0.87 0.91 0.88 0.91 1.11 1.18 1.27 1.33 1.45 1.42 1.44 1.66 1.63 1.63 1.80
Deferred tax liabilities 0.04 0.04 0.05 0.05 0.05 0.06 0.06 0.30 0.32 0.34 0.07 0.07 0.07 0.07 0.08 0.09 0.10 0.11 0.11 0.12 0.12 0.13 0.14 0.15 0.17 0.19
Capital lease obligation, net of current portion 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.18 2.35 2.82 3.14 3.36 0.00
Long-term liabilities 1.34% 1.57% 1.89% 2.08% 2.06% 2.59% 2.39% 3.26% 3.04% 2.98% 1.57% 1.96% 1.84% 1.98% 1.09% 1.32% 1.38% 1.48% 1.55% 1.64% 3.80% 4.01% 5.22% 4.93% 5.17% 2.04%
Total liabilities 9.24% 9.83% 10.16% 10.04% 9.51% 10.35% 11.02% 11.69% 10.96% 11.82% 12.41% 12.51% 11.82% 10.89% 11.14% 11.03% 10.62% 10.92% 12.32% 12.11% 12.92% 13.06% 17.87% 16.68% 16.10% 12.11%
Class B Preferred Stock, $.01 par value; none issued and outstanding 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, $.01 par value 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.04 0.04 0.05 0.05 0.06 0.06 0.06 0.06 0.07 0.08 0.09 0.09 0.10
Additional paid in capital 53.33 51.95 51.99 53.56 54.93 55.91 53.58 54.74 57.80 59.98 60.76 61.26 64.22 62.65 65.49 70.65 74.41 78.56 78.83 84.17 85.23 88.93 102.82 109.15 113.05 121.32
Retained earnings (accumulated deficit) 66.32 59.82 57.64 56.76 56.11 54.96 55.41 53.99 53.41 51.79 49.53 47.69 44.60 43.41 37.89 34.01 31.63 28.39 17.86 14.40 12.98 10.07 -8.53 -12.35 -16.28 -20.07
Treasury stock at cost -26.17 -19.37 -18.20 -19.11 -19.62 -20.41 -19.27 -20.15 -21.66 -22.94 -21.82 -20.08 -19.12 -15.94 -13.17 -14.45 -15.41 -16.58 -8.53 -9.26 -9.50 -9.90 -8.50 -9.29 -9.74 -9.71
Accumulated other comprehensive loss -2.75 -2.25 -1.62 -1.29 -0.95 -0.84 -0.77 -0.29 -0.54 -0.68 -0.92 -1.42 -1.56 -1.04 -1.39 -1.29 -1.30 -1.34 -0.53 -1.48 -1.70 -2.22 -3.74 -4.28 -3.22 -3.75
Stockholders’ equity 90.76% 90.17% 89.84% 89.96% 90.49% 89.65% 88.98% 88.31% 89.04% 88.18% 87.59% 87.49% 88.18% 89.11% 88.86% 88.97% 89.38% 89.08% 87.68% 87.89% 87.08% 86.94% 82.13% 83.32% 83.90% 87.89%
Total liabilities and stockholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-K (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-K (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-K (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-K (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-K (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-K (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30).

The capital structure exhibits a strong reliance on equity financing, with total liabilities consistently representing a small fraction of the total balance sheet. Total liabilities peaked at 17.87% in March 2017 before trending downward to 9.24% by September 2022. This indicates a conservative leverage profile and a high degree of financial solvency throughout the observed period.

Current Liabilities and Working Capital
Current liabilities have fluctuated within a narrow range, generally moving from approximately 10% to 8% of total liabilities and stockholders’ equity. Accounts payable and accrued expenses comprise the bulk of these obligations. Accrued expenses showed a gradual decline from 6.12% in June 2016 to 4.09% in September 2022, suggesting improved management of short-term obligations or a shift in the timing of expense recognition relative to overall asset growth.
Long-Term Obligations
Long-term liabilities have remained minimal, decreasing from a peak of 5.22% in March 2017 to 1.34% by September 2022. The reduction in deferred tax liabilities and the stability of contingent consideration contribute to this decline. The absence of significant long-term debt indicates that growth has been funded primarily through internal cash flows and equity rather than long-term borrowing.
Equity Composition and Retained Earnings
The most significant transformation is observed in the equity components. Retained earnings transitioned from a substantial accumulated deficit of -20.07% in June 2016 to a positive 66.32% by September 2022. This reversal signifies a pivot from early-stage losses to sustained profitability, with internally generated capital becoming the primary driver of the company's book value.
Capital Contributions and Share Buybacks
Additional paid-in capital decreased significantly as a percentage of the total balance sheet, falling from 121.32% in June 2016 to 53.33% in September 2022. This decline is relative, reflecting the rapid growth of retained earnings rather than a reduction in absolute capital. Concurrently, treasury stock increased in magnitude from -9.71% to -26.17%, indicating an aggressive program of share repurchases over the period.
Overall Solvency Trend
Stockholders' equity has remained dominant, ending the period at 90.76% of total liabilities and stockholders' equity. The combination of decreasing total liabilities and the surge in retained earnings underscores a robust financial position characterized by minimal credit risk and high internal funding capacity.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?